As the first and only all-in-one hands-free device cleared by the FDA, EvolveX is at the forefront of the market, delivering multiple non-invasive procedures on one system. EvolveX is InMode’s formal entry into the hands-free market and is founded on a unique three-dimensional approach to tissue remodeling. Its innovative design deploys three proprietary technologies – Tite, Transform, and Tone – allowing for customized treatment for a variety of body types.
Dr. Erez Dayan, plastic and reconstructive surgeon, commented, “Today’s patients are seeking a customizable and effective solution for their aesthetic goals. This is the first time that I have the ability to offer a non-invasive solution tailored to my patient’s needs. The EvolveX platform is clinically the most effective solution available for the treatment of skin, fat and muscle. With the great results that are achieved, we see high levels of patient satisfaction.”
“Our ability and success in bringing innovative solutions to the market are derived directly from listening carefully to our customers. The demand for an all-inclusive body solution in the non-invasive space is long overdue. We are proud to be the first company to offer the full range of treatments from non-invasive to minimally invasive in this segment. This exciting new technology is the latest addition to the InMode portfolio; as we continue to innovate, this ecosystem will only become more robust,” said Shakil Lakhani, President of North America at InMode.
For more information about InMode and our wide array of medical technologies, visit www.inmodemd.co.uk